Betaxolol HCl

貨號 Cat. No.
S1827
規格 Size
10mM/1mL~50mg
品牌 Brand
Selleckchem

Description


Betaxolol HCl
Catalog No.S1827

Betaxolol is a β1 adrenergic receptor blocker with IC50 of 6 μM.


















Size Price Stock Quantity  






















10mM/1mLIn DMSO USD 113 In stock  
0
 
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
10mg USD 88 In stock  
0
 
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
50mg USD 214 In stock  
0
 
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 




 Distributor Tel: +886-2-2827-1197jimmy@new.abscience.com.tw



Biological Activity







































Description Betaxolol is a β1 adrenergic receptor blocker with IC50 of 6 μM.
Targets β1 adrenergic receptor          
IC50 6 μM [1]          
In vitro Betaxolol is able to protect retinal neurones. [2] Betaxolol attenuates the NMDA-induced influx of 45Ca2+ while β-adrenoreceptor agonists are ineffective. [3] The glutamate-induced release of LDH is almost completely prevented when betaxolol (10 μM) is included. [4] Betaxolol (100 μM) is very effective in preventing the hypoxia-induced release of LDH from cortical cultures. [5]
In vivo When Betaxolol is injected i.p. into the rats before ischaemia and on the days of reperfusion the changes to the calretinin and ChAT immunoreactivities are reduced and the reduction of the b-wave is prevented. Inclusion of betaxolol partially prevents the changes caused by NMDA and lack of oxygen/glucose. [5]
Features  

Protocol(Only for Reference)


Cell Assay: [5]





















Cell lines Dissociated rat cortical cells
Concentrations 100 μM
Incubation Time 4 hours
Method Dissociated cortical cells from 16–18-day-old fetal rats are grown, in 35 mm dishes, in DMEM supplemented with L-glutamine (4 mM), glucose (6 g/L), penicillin (100 U/mL), streptomycin (100 μg/mL) and 10% hormonal supplemented medium consisting of transferrin (1 mg/mL), insulin (250 μg/mL) putrescine (600 μM), sodium selenite (0.3 μM), progesterone (0.2 μM) and estradiol (0.1 pM) for 7 days in an atmosphere of 5% CO2/95% O2at 37 °C. The cultures are then transferred to a culture medium which lacks the hormonal supplemented medium. L-glutamate is added to the medium and incubated for a further 4 hours under normoxic conditions. Betaxolol are added to the cultures at the same time as L-glutamate. In other experiments the cultures are subjected to anoxic conditions, 95% N2/5% CO2, for 5 hours at 37 °C. Betaxolol is added prior to anoxia. Reoxygenation is then achieved by replacing the cells in normoxic conditions (95% O2/5% CO2) for 3 hours. Cellular injury is assessed by measuring lactate dehydrogenase (LDH) release into the cell culture supernatant after hypoxia/reoxygenation or glutamate exposure. LDH activity is assayed spectrophotometrically by following NADH metabolism for 2 minutes at 340 nm.

Animal Study: [5]





















Animal Models Rat wiht ischaemia
Dosages 2.5 mg/kg
Administration Administered via i.p.
Solubility Saline, 30 mg/mL

1

References


Chemical Information


Download Betaxolol HCl SDF
 

















Molecular Weight (MW) 343.89
Formula

C18H29NO3.HCl


CAS No. 63659-19-8















Storage 3 years -20℃Powder
6 months-80℃in DMSO
Syonnyms Lokren ,Kerlone

 


























Solubility (25°C) * In vitro DMSO 69 mg/mL (200 mM)
Water 69 mg/mL (200 mM)
Ethanol 69 mg/mL (200 mM)
In vivo Saline, 30 mg/mL
* <1 mg/ml means slightly soluble or insoluble.

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.


 








Chemical Name  

 

Preparing Stock Solutions



















Stock Solution (1ml DMSO) 1mM 10mM 20mM 30mM
Mass(mg) 0.34389 3.4389 6.8778 10.3167



 


 


 


 


 

詢價 / 洽詢此產品

同品牌其他產品

回到產品列表

▲ LINE
諮詢